Back to Results
First PageMeta Content
Health / Amyotrophic lateral sclerosis / SOD1 / James Heywood / ALS Society of Canada / ALS Therapy Development Institute / Rare diseases / Motor neurone disease


A n n u al r e p o r t[removed] Letter from the CEO The ALS Therapy Development Institute (ALS TDI) was founded because of one family’s belief that there had to be a better, more efficient, and faster way to develop t
Add to Reading List

Document Date: 2014-05-20 08:32:13


Open Document

File Size: 798,77 KB

Share Result on Facebook

City

Washington / Yakima / Cambridge / Orange / Marilou Town / /

Company

Anida Pharma / Boston Business Journal / Wyeth / Third Rock Ventures / UCB Pharma / ALSTDI / Biogen Idec / Financial Review / Neurimmune / Pfizer / TDI / to-BBB / J.D. / D. / Michael M. Smith Corporate Officers / /

Country

United States / /

Currency

USD / cent / /

/

Event

Person Communication and Meetings / Business Partnership / FDA Phase / /

Facility

Bell’s Brewery / Northeastern University / University of Massachusetts Medical School / Georgia Regents University / Beth Israel Deaconess Medical Center / University of California / Massachusetts General Hospital / Brandeis University / Methodist Neurological Institute / Harpoon Brewery / /

/

IndustryTerm

info@als.net WEB / internet hoping / biotechnology industry experience / biotechnology / healthcare / iPS cell technology / /

MedicalCondition

complex disease / ALS / Parkinson’s disease / fibrosis / significantly reduced muscle atrophy / horrid disease / chronic antibody treatment / disease / highly complex disease / /

NaturalFeature

Russian River / /

Organization

Georgia Regents University / Northeastern University / University of California / Irvine / Methodist Neurological Institute in Houston / ALS TDI’s mission / ALS / FDA / University of California / San Francisco / Brandeis University / Internal Revenue Service / Beth Israel Deaconess Medical Center / Stanford University School of Medicine / ALS TDI Board of Directors Augie Nieto / ALS Therapy Development Institute / Cystic Fibrosis Foundation / Massachusetts General Hospital in Boston / University of Massachusetts Medical School / Hop Union / Legacy Giving Society / /

Person

Jerry De Zutter / Rick Cochran / Jenny Gore Dwyer / Rodin Ted Reich / Julie Swan / Cover Image / Jennifer Gore Dwyer / D. Alexander Cappello Jenny / Kevin Swan / Julie Donnelly / Joan Melanson / Augie Nieto / Robert Sepucha Jr. / Ted Reich / Matvey Lukashev / Willem van Weperen / Jean Saling / Roger Petrone Jr / Peggy Heywood / Robert Beall / Ken Thompson / Nancy Frates / Spiros Jamas / Gladstone Institutes / Fernando G. Vieira / Mike Smith / Andy Rubenstein / Wendy Reich / James Allen Heywood John / Philip Reilly / John B. Heywood / Steve Finkbeiner / Corey Reich / Alexandra Tsolias / Robert Sepucha / Jan Grimm / Keith Melanson Rob Rodin Ted / John Mallett / Jenny Dwyer / Aaron Gitler / Bill / Stanley H. Appel / Steve Perrin / Steve Saling / Michael Gold / Michael M. Smith / D. Michael M. Smith / Cheryl Smith / Jessie St. Martin Associate / Robert Sepucha / Jr. / /

/

Position

Vice Chairman / President / Director of Operations & Assistant Clerk / Research Associate / advocate / Support General / CEO / professor / CPA Secretary / policy and business development executive / CFO / Bruce Hain Treasurer / VP clinical therapeutic area CNS / Director of Translational Research / Scientist / associate professor of genetics / CPA / Chairman / associate director and senior investigator / healthcare and life sciences reporter / president & CEO / CEO & Chief Scientific Officer / CFO / Ph. CFO / Bruce Hain Treasurer / Ph. CEO & Chief Scientific Officer / Ph. President / Ph. CEO / /

Product

ALS™ / ALS / TDI-132 / /

ProvinceOrState

Washington / California / Massachusetts / /

PublishedMedium

the Boston Business Journal / /

Technology

stem cells / drug discovery / antibodies / biotechnology / iPS cell technology / drug development / /

URL

www.als.net / www.als.net/ips / www.alesforals.com / /

SocialTag